The ALCHEMIST Lung Cancer Trials
A collection of material about the ALCHEMIST lung cancer trials that will examine tumor tissue from patients with certain types of early-stage, completely resected non-small cell lung cancer for gene mutations in the EGFR and ALK genes, and assign patients with these gene mutations to treatment trials testing post-surgical use of drugs targeted against these mutations.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/814247/syndication
- Syndication ID: 3571
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Saturday, August 29, 2015 at 01:00 AM
- Date Syndication Updated: Monday, August 05, 2019 at 07:43 PM
Tags
General:
lung
NSCLC
ALK
EGFR
crizotinib
erlotinib
Embed Code Snippet
To get the embed code snippet please Login.
